Deferred therapy in well and moderately differentiated prostate cancer.
One hundred and twenty-two patients with localized prostate cancer were included in a surveillance study. The risk of developing metastases and dying of prostate cancer after 10 years was 20 and 15% respectively. These figures are comparable with results in recent reports on long-term follow-up of after radical prostatectomy and radiation therapy.
Adolfsson
J
J
Department of Urology, Karolinska Hospital, Stockholm, Sweden.
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D013997:Time Factors